Project Grant R56AT011869
Award Date
9/14/23
Completion Date
8/31/24
Dollars Obligated
$475K
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Center for Complementary and Integrative Health
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
The National Center for Complementary and Integrative Health (NCCIH), a component of the National Institutes of Health (NIH), awarded a $170,604 Project Grant under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the "RESILIENT TOGETHER-ALS (RT-ALS): A DYADIC MIND-BODY MEANING INTERVENTION FOR PEOPLE WITH ALS AND THEIR INFORMAL CARE-PARTNERS" project....
This federal Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $976,424 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct a randomized controlled trial of a preventive behavioral intervention called Resilience Training (RT) for young adults with psychotic experiences. The study aims to evaluate whether RT can reduce psychotic experiences, anxiety, depression, and...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $459,250 federal Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242). The 2-year grant, running from August 15, 2023 to August 14, 2025, will fund research to investigate the state-dependent effects of transcranial alternating current stimulation (TACS) on theta-gamma cross-frequency coupling and fronto-parietal...
This federal Project Grant award of $901,954 from the Defense Health Agency supports research led by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to assess the molecular basis of microbiome-gut-brain signaling in autism spectrum disorder. The research will utilize a humanized zonulin transgenic mouse model and human intestinal organoids. This work is funded under the Military Medical Research and Development program (CFDA 12.420), which provides...
The U.S. Defense Health Agency awarded The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a $1,140,766 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2024 through August 31, 2027, will fund a novel mHealth balance assessment and rehabilitation project using computer vision and AI for patients with neurofibromatosis type 2 (NF2). MGH, as the primary research institution, will...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $129,288 in funding to The General Hospital Corporation (doing business as Massachusetts General Hospital) from August 1, 2024 to July 31, 2026. The purpose of this award is to develop statistical methods and analytical resources to enable fine-mapping of genetic variants associated with psychiatric disorders, with a focus on integrating data...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $320,000.00 in funding to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on "GAMMA DELTA T CELL LIGANDS IN MS". The award period runs from November 1, 2024 to October 31, 2026. As a major recipient of federal research funding, MGH will leverage its extensive...
The National Institute of Mental Health (NIMH) awarded a $245,475 Project Grant (CFDA 93.242 - Mental Health Research Grants) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on defining the neuro-immune and placental profile of a dual-hit Toll-Like Receptor 7 (TLR7) and stressor mouse model. The key objectives of this 2-year research project are to determine whether prenatal TLR7 stimulation induces maternal, placental, and...
The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital (MGH), received a $563,724 Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support (CFDA 93.310) program. The project aims to provide a comprehensive, national picture of the links between substance use, firearm injuries, and reinjury in a sample of 42 million Medicaid-enrolled youth aged 13-25 across the U.S. from 2016-2020. The project seeks to...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...